DUBLIN--(BUSINESS WIRE)--The "Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, & Forecasts, 2025" report has been added to ResearchAndMarkets.com's offering. Since the ...
Taiwan’s biotech industry is living its golden days, and LumiSTAR is certainly one of its shining examples. It all started at Oxford University, when LumiSTAR co-founders Yu-Fen Chang, CEO, and ...
In Alzheimer’s and other diseases with complex genetics, differentiating a single induced pluripotent stem cell (iPSC) line from a single endpoint cell may improperly represent the underlying ...
CAMBRIDGE, Mass. & ATLANTA & SEOUL, South Korea--(BUSINESS WIRE)--Cellino, a biotechnology company pioneering autonomous biomanufacturing for personalized regenerative medicine, today announced its ...
Cellino, a biotechnology firm working on autonomous biomanufacturing for personalized regenerative medicines, has signed a strategic collaboration with Karis Bio, a South Korean cell therapy company, ...
BEACHWOOD, Ohio, Aug. 5, 2025 /PRNewswire/ -- Trailhead Biosystems, Inc. (TrailBio.com), a biotechnology company advancing scalable human cell models derived from induced pluripotent stem cells (iPSCs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback